UMass Amherst researchers, led by Assistant Prof. Dmitry Kireev, are developing a temporary tattoo that analyzes sweat for health monitoring, with NSF funding. The device may revolutionize personal health management.

Researchers at UMass Amherst have developed a new simulation method to better understand the behavior of intrinsically disordered proteins, which are linked to diseases such as cancer.

MIT physicists have found that stars on the Milky Way's edge travel slower, suggesting less dark matter there than expected. This challenges previous beliefs about dark matter distribution in the galaxy.

A gene therapy trial in China shows that five deaf children gained the ability to hear, heralding a major medical advancement.

MIT engineers have developed a model potentially revolutionizing running shoe design by predicting the impact of shoe properties on a runner's gait and performance.

UMass Amherst engineer Stacyann Bailey receives a $392,617 grant to study how cancer treatments, especially immunotherapies, might contribute to bone fractures in patients with metastatic disease.

MIT scientists develop a forecasting tool to project increased flood risks from hurricanes in coastal cities as the climate warms, incorporating storm surge and rainfall interactions.

Massachusetts Senate passed a bill to legalize fentanyl test strips to reduce overdose deaths. These strips will allow users to detect fentanyl in drugs, addressing the state's overdose crisis.

Dana-Farber Cancer Institute plans to retract six studies and correct 31 others after claims of data manipulation surfaced, prompting internal review and scrutiny over research integrity.

A study found that children from less affluent families may have brains with lower reward sensitivity, potentially impacting neurodevelopment and motivation.

MIT researchers have developed a self-powered sensor that exploits magnetic energy, offering maintenance and diagnostics advantages in locations like ship engines without the need for batteries or wiring.

Scientists at MIT and Yale have discovered that a drug candidate, initially for cancer, shows potential as a treatment for polycystic kidney disease by shrinking kidney cysts.

Diabetes medications Wegovy and Zepbound, originally for blood sugar control, gain FDA approval as obesity treatments, offering significant weight loss benefits.